.png?width=109&height=108&name=Pharma%20(2).png)
.png?width=111&height=108&name=Medical%20Devices%20(2).png)
.png?width=84&height=107&name=IVD%20(2).png)
Unlocking Strategic Value in Drug Safety for Life Sciences Organizations
On demand
1h
Pharma
English
Share
Agenda
00:00 – Introduction – Dr. Ángel Navarro
09:21 – Unlocking the value of the integrated Approach to Drug Safety – Dr. Antonio Borregón
20:27 – Patient-Centric approacher to Pharmacovigilance – Dr. Richard Habis
30:50 – Conclusions
09:21 – Unlocking the value of the integrated Approach to Drug Safety – Dr. Antonio Borregón
20:27 – Patient-Centric approacher to Pharmacovigilance – Dr. Richard Habis
30:50 – Conclusions
Speakers
Dr. Ángel Navarro
Country Manager Spain & Head of Global Vigilance Division
Dr. Angel Navarro is the Country Manager of Spain of QbD Group and Head of Vigilance Division. Founder and CEO of Azierta for more than 12 years (Azierta part of QbD Group), his track record endorses him as a strategic leader in the international pharmaceutical sector.
Dr. Antonio Borregón
Head Global Business Development Pharma
Dr. Antonio Borregón is the Global Business Development Pharma Head at QbD Group. He has extensive experience in the pharmaceutical field with high-responsibility positions at the international level.
Dr. Richard Habis
Richard Habis, a PharmD graduate from Saint Joseph University of Beirut, is a seasoned expert in biopharmaceutical consulting and market research. With a keen focus on rare diseases and patient-centered care, his expertise extends to leveraging real-world data to drive patient outcomes and healthcare insights. Mr. Habis’s professional journey reflects a strong commitment to integrating patient perspectives in digital health solutions.
We share the latest news
Staying on top of the latest in the life science industry can be a daunting task. This newsletter will keep you up-to-date with the latest news, blogs and webinars so you can keep ahead of the curve.
